, Volume 16, Issue 1, pp 107–113 | Cite as

Survival benefit of multimodal local therapy for repeat recurrence of thoracic esophageal squamous cell carcinoma after esophagectomy

  • Itasu NinomiyaEmail author
  • Koichi Okamoto
  • Sachio Fushida
  • Jun Kinoshita
  • Hiroyuki Takamura
  • Hidehiro Tajima
  • Isamu Makino
  • Tomoharu Miyashita
  • Tetsuo Ohta
Original Article



This study was performed to clarify the optimal therapeutic strategy for recurrent disease after esophagectomy.


We investigated the prognosis of 37 patients who developed recurrence among 128 patients who underwent curative thoracoscopic esophagectomy (TE) at Kanazawa University Hospital. The prognostic factors after recurrence were examined by univariate and multivariate analyses.


Of these 37 recurrences, 29 patients underwent local therapy (surgery, 10 patients; surgery followed by radiation, 2 patients; radiation, 17 patients). Radiation includes intensity-modulated radiation therapy, chemoradiation, and simple radiation therapy. Seventeen patients (58.6%) were considered to have undergone successful therapy by disappearance or diminishment of the targeted region without regrowth. Eleven of 17 patients (64.7%) showed repeat recurrence at another site. Multiple local therapy was performed for repeat recurrence or uncontrollable first therapy. Finally, 57 local therapies were performed. Using multimodal local therapy, 37 (64.9%) of 57 recurrences were successfully managed. The 12 patients treated by surgery as the initial therapy showed the most favorable survival. Seventeen patients who underwent successful initial therapy showed better survival than others. Multiple or miscellaneous organ metastasis, abdominal lymphatic recurrence and best supportive care at recurrence were statistically significant negative variables for survival after recurrence. Performance of surgery and successful therapy as the initial recurrence were statistically significant positive variables for survival after recurrence. Multivariate analysis showed that successful therapy at the initial recurrence was the only independent variable for survival after recurrence.


Multimodal local therapy for repeat recurrence after TE contributes to the improvement of survival after recurrence.


Esophageal neoplasm Recurrence Surgery Intensity-modulated radiotherapy 



The authors thank Dr. Isao Matsumoto from the Department of Thoracic, Cardiovascular and General Surgery for resection of the lung metastasis and Dr. Tsuyoshi Takanaka from the Department of Radiation Oncology for performance of the radiation therapy.

Compliance with ethical standards

Ethical Statement

All patients provided written informed consent before the treatment, and the study was approved by the Ethics Committee of Kanazawa University Hospital. This work conforms to the guidelines set forth in the Helsinki Declaration of 1975 and later versions.

Conflict of interest

All authors declare that they have no conflict of interest.


  1. 1.
    Bhansali MS, Fujita H, Kakegawa T, et al. Pattern of recurrence after extended radical esophagectomy with three-field lymph node dissection for squamous cell carcinoma in the thoracic esophagus. World J Surg. 1997;21:275–81.CrossRefGoogle Scholar
  2. 2.
    Mariette C, Balon JM, Piessen G, et al. Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer. 2003;97:1616–23.CrossRefGoogle Scholar
  3. 3.
    Nakagawa S, Kanda T, Kosugi S, et al. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy. J Am Coll Surg. 2004;198:205–11.CrossRefGoogle Scholar
  4. 4.
    Miyata H, Yamasaki M, Kurokawa Y, et al. Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas. Ann Surg Oncol. 2011;18:3353–61.CrossRefGoogle Scholar
  5. 5.
    Ninomiya I, Osugi H, Fujimura T, et al. Results of video-assisted thoracoscopic surgery for esophageal cancer during the induction period. Gen Thorac Cardiovasc Surg. 2008;56:119–25.CrossRefGoogle Scholar
  6. 6.
    Ninomiya I, Okamoto K, Fujimura T, et al. Oncologic outcomes of thoracoscopic esophagectomy with extended lymph node dissection: 10-year experience from a single center. World J Surg. 2014;38:120–30.CrossRefGoogle Scholar
  7. 7.
    Ninomiya I, Okamoto K, Tsukada T, et al. Recurrence patterns and risk factors following thoracoscopic esophagectomy with radical lymph node dissection for thoracic esophageal squamous cell carcinoma. Mol Clin Oncol. 2016;4:278–84.CrossRefGoogle Scholar
  8. 8.
    Thomson IG, Smithers BM, Gotley DC, et al. Thoracoscopic-assisted esophagectomy for esophageal cancer: analysis of patterns and prognostic factors for recurrence. Ann Surg. 2010;252:281–91.CrossRefGoogle Scholar
  9. 9.
    Yano M, Takachi K, Doki Y, et al. Prognosis of patients who develop cervical lymph node recurrence following curative resection for thoracic esophageal cancer. Dis Esophagus. 2006;19:73–7.CrossRefGoogle Scholar
  10. 10.
    Watanabe M, Nishida K, Kimura Y, et al. Salvage lymphadenectomy for cervical lymph node recurrence after esophagectomy for squamous cell carcinoma of the thoracic esophagus. Dis Esophagus. 2012;25:62–6.CrossRefGoogle Scholar
  11. 11.
    Nakamura T, Ota M, Narumiya K, et al. Multimodal treatment for lymph node recurrence of esophageal carcinoma after curative resection. Ann Surg Oncol. 2008;15:2451–7.CrossRefGoogle Scholar
  12. 12.
    Watanabe M, Mine S, Yamada K, et al. Outcomes of lymphadenectomy for lymph node recurrence after esophagectomy or definitive chemoradiotherapy for squamous cell carcinoma of the esophagus. Gen Thorac Cardiovasc Surg. 2014;62:685–92.CrossRefGoogle Scholar
  13. 13.
    Takemura M, Sakurai K, Takii M, et al. Metachronous pulmonary metastasis after radical esophagectomy for esophageal cancer: prognosis and outcome. J Cardiothorac Surg. 2012;7:103.CrossRefGoogle Scholar
  14. 14.
    Taguchi S, Osugi H, Higashino M, et al. Comparison of three-field esophagectomy for esophageal cancer incorporating open or thoracoscopic thoracotomy. Surg Endosc. 2003;17:1445–50 Epub 2003 Jun 19.CrossRefGoogle Scholar
  15. 15.
    Kobayashi R, Yamashita H, Okuma K, et al. Salvage radiation therapy and chemoradiation therapy for postoperative locoregional recurrence of esophageal cancer. Dis Esophagus. 2014;27:72–8.CrossRefGoogle Scholar
  16. 16.
    Nutting CM, Bedford JL, Cosgrove VP, et al. A comparison of conformal and intensity-modulated techniques for oesophageal radiotherapy. Radiother Oncol. 2001;61:157–63.CrossRefGoogle Scholar
  17. 17.
    Chandra A, Guerrero TM, Liu HH, et al. Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer. Radiother Oncol. 2005;77:247–53.CrossRefGoogle Scholar
  18. 18.
    Kole TP, Aghayere O, Kwah J, et al. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer. Int J Radiat Oncol Biol Phys. 2012;83:1580–6.CrossRefGoogle Scholar
  19. 19.
    Du XL, Sheng XG, Jiang T, et al. Intensity-modulated radiation therapy versus para-aortic field radiotherapy to treat para-aortic lymph node metastasis in cervical cancer: prospective study. Croat Med J. 2010;51:229–36.CrossRefGoogle Scholar

Copyright information

© The Japan Esophageal Society and Springer Japan KK, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Gastroenterological SurgeryKanazawa UniversityKanazawaJapan

Personalised recommendations